Aptose Biosciences (APTO) Revenue & Revenue Breakdown
Aptose Biosciences Revenue Highlights
00
Aptose Biosciences Revenue by Period
Aptose Biosciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-05-31 | - | 100.00% |
2013-05-31 | - | 100.00% |
2012-05-31 | - | 100.00% |
2011-05-31 | - | -100.00% |
2010-05-31 | $124.16K | -26.45% |
2009-05-31 | $168.81K | 292.36% |
2008-05-31 | $43.02K | -56.99% |
2007-05-31 | $100.02K | 316.75% |
2006-05-31 | $24.00K | 380.11% |
2005-05-31 | $5.00K | -98.88% |
2004-05-31 | $446.69K | 834.06% |
2003-05-31 | $47.82K | 100.00% |
2002-05-31 | - | -100.00% |
2001-05-31 | $1.00K | 49.88% |
2000-05-31 | $667.40 | -99.02% |
1999-05-31 | $67.82K | -1.21% |
1998-05-31 | $68.65K | -5.38% |
1997-05-31 | $72.56K | - |
Aptose Biosciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $712.21K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-05-31 | - | 100.00% |
2014-02-28 | - | 100.00% |
2013-11-30 | - | 100.00% |
2013-08-31 | - | 100.00% |
2013-05-31 | - | 100.00% |
2013-02-28 | - | 100.00% |
2012-11-30 | - | 100.00% |
2012-08-31 | - | 100.00% |
2012-05-31 | - | 100.00% |
2012-02-29 | - | 100.00% |
2011-11-30 | - | 100.00% |
2011-08-31 | - | 100.00% |
2011-05-31 | - | 100.00% |
2011-02-28 | - | 100.00% |
2010-11-30 | - | 100.00% |
2010-08-31 | - | -100.00% |
2010-05-31 | $-474.84 | -116.64% |
2010-02-28 | $2.85K | -96.18% |
2009-11-30 | $74.69K | 66.95% |
2009-08-31 | $44.74K | -47.56% |
2009-05-31 | $85.31K | 69.23% |
2009-02-28 | $50.41K | 63.06% |
2008-11-30 | $30.92K | 100.00% |
2008-08-31 | - | -100.00% |
2008-05-31 | $11.93K | 296.21% |
2008-02-29 | $3.01K | - |
Aptose Biosciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
CTMX | CytomX Therapeutics | $101.21M | $33.43M |
SPRO | Spero Therapeutics | $96.73M | $13.47M |
ADAP | Adaptimmune Therapeutics | $60.28M | $128.23M |
FBIO | Fortress Biotech | $59.66M | $14.63M |
AFMD | Affimed | $8.28M | $155.00K |
ASMB | Assembly Biosciences | $7.16M | $6.84M |
AGLE | Spyre Therapeutics | $2.33M | - |
TFFP | TFF Pharmaceuticals | $733.87K | $650.22K |
LIFE | aTyr Pharma | $353.00K | $235.00K |
GANX | Gain Therapeutics | $55.18K | - |
CRVS | Corvus Pharmaceuticals | - | - |
APTO | Aptose Biosciences | - | - |
MBIO | Mustang Bio | - | - |
LBPH | Longboard Pharmaceuticals | - | - |
LPTX | Leap Therapeutics | - | - |
TIL | Instil Bio | - | - |
INAB | IN8bio | - | - |
NLTX | Neurogene | - | - |
ACHL | Achilles Therapeutics | - | - |
ONCT | Oncternal Therapeutics | - | - |
LTRN | Lantern Pharma | - | - |